Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jelle L. Vosters"'
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51375 (2012)
CD40-CD154 (CD40 ligand) interaction in the co-stimulatory pathway is involved in many (auto)immune processes and both molecules are upregulated in salivary glands of Sjögren's syndrome (SS) patients. Interference within the CD40 pathway has amelior
Externí odkaz:
https://doaj.org/article/af38082c2d02445080fe10e5c6f1312e
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e19962 (2011)
Intercellular adhesion molecule-1 (ICAM-1) is involved in migration and co-stimulation of T and B cells. Membrane bound ICAM-1 is over expressed in the salivary glands (SG) of Sjögren's syndrome (SS) patients and has therefore been proposed as a pot
Externí odkaz:
https://doaj.org/article/e7e94273db88427781e2ce01653f7fed
Autor:
Hongen Yin, Jelle L Vosters, Nienke Roescher, Anil D'Souza, Biji T Kurien, Paul P Tak, John A Chiorini
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e18003 (2011)
INTRODUCTION: Anti-Ro antibodies can be found in the serum of the majority of patients with Sjögren's syndrome (SS). Immunization with a 60-kDa Ro peptide has been shown to induce SS-like symptoms in mice. The aim of this study was to investigate fa
Externí odkaz:
https://doaj.org/article/69ba32f632aa41c49dcee4295d2d2816
Autor:
PP Tak, Patrick A. Dreyfus, Sébastien Jacques, Gilles Chiocchia, Jelle L. Vosters, Nienke Roescher, John A. Chiorini, Jean Sibilia, Ghada Alsaleh, Xavier Mariette, Jacques-Eric Gottenberg
Publikováno v:
Molecular therapy, 22(4), 821-827. Nature Publishing Group
BAFF (B-cell–activating factor of the tumor necrosis factor family), a pivotal cytokine for B-cell activation, is overexpressed by salivary gland (SG) epithelial cells in primary Sjogren's syndrome (pSS). ΔBAFF, a physiological inhibitor of BAFF,
Publikováno v:
Rheumatology (Oxford, England), 51(9), 1557-1562. Oxford University Press
Objective. A proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF) are B-cell-related mediators and may play a role in the pathogenesis in SS. In this descriptive study we assessed the expression of APRIL and BAFF in the minor sal
Publikováno v:
Oral Diseases. 18:365-374
Objective Sjogren’s syndrome (SS) patients show aberrant expression of the B cell-related mediators B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in serum and salivary glands (SGs). We studied the biological effect of
Autor:
BM Lodde, Paul P. Tak, Jelle L. Vosters, Gabor G. Illei, Nienke Roescher, Marcelo A. Catalán, John A. Chiorini
Publikováno v:
Oral Diseases. 18:96-106
Oral Diseases (2011) 18, 96–106 Objective: Non-obese diabetic (NOD) mice develop an autoimmune exocrinopathy that shows similarities with Sjogren’s syndrome. They provide an experimental model to study the pathoetiogenesis of this disease. Materi
Autor:
John A. Chiorini, Paul P. Tak, William D. Swaim, Patrizio Caturegli, Melissa A. Landek-Salgado, Hiroaki Kimura, Hongen Yin, Jelle L. Vosters
Publikováno v:
Arthritis and rheumatism, 60(12), 3633-3641. John Wiley and Sons Inc.
Objective Interleukin-12 (IL-12) is a pleiotropic cytokine that is elevated in the affected organs of patients with Sjogren's syndrome (SS). We have previously reported that overexpression of IL-12 in CBA mice leads to mononuclear infiltration of sal
Autor:
Niels Broekstra, F. A. Koopman, Margriet J. Vervoordeldonk, Jelle L. Vosters, Paul P. Tak, Nienke Roescher
Publikováno v:
Oral diseases, 21(7), 858-865. Wiley-Blackwell
Objective Activation of the cholinergic anti-inflammatory pathway (CAP) has been shown to reduce inflammation in animal models, while abrogation of the pathway increases inflammation. We investigated whether modulation of CAP influences inflammation
Publikováno v:
Future Rheumatology. 1:433-440
Sjogren’s syndrome (SS) is a complex autoimmune disorder characterized by mononuclear infiltration of the exocrine glands. There is an increased interest to use immunomodulatory protein therapy to target inflammatory components thought to be import